Hanna Cisoń, Paulina Kostrzewska, Natalia Łątka, Piotr K Krajewski, Jacek Szepietowski, Alina Konsur-Jankowska, Rafał Białynicki-Birula, Adam Reich
{"title":"Awareness of people using municipal swimming pools about the prevention, symptoms, and treatment of athlete's foot and onychomycosis before COVID-19.","authors":"Hanna Cisoń, Paulina Kostrzewska, Natalia Łątka, Piotr K Krajewski, Jacek Szepietowski, Alina Konsur-Jankowska, Rafał Białynicki-Birula, Adam Reich","doi":"10.5114/ada.2024.136083","DOIUrl":"10.5114/ada.2024.136083","url":null,"abstract":"<p><strong>Introduction: </strong>Superficial mycosis is one of the most common diseases worldwide; however, its epidemiology is changing over time.</p><p><strong>Aim: </strong>To present the awareness of people using swimming pools about athlete's foot and onychomycosis.</p><p><strong>Material and methods: </strong>A total of 690 participants were subjected to an extensive survey administered via Google Documents. The questionnaire consisted of 30 online polling items and aimed to evaluate respondents' knowledge pertaining to fungal infections, encompassing aspects such as prevention strategies, disease trajectory, and therapeutic modalities. The survey sample specifically encompassed students and sports enthusiasts associated with 33 Internet groups, and data collection transpired during the period spanning 12 January to 15 March, 2018, predating the advent of the COVID-19 pandemic.</p><p><strong>Results: </strong>In the study, 85.2% of participants regularly inspected their feet, with 4.8% seeking podiatric services. While 75.2% demonstrated hygienic behaviour by changing towels after each pool visit, 41.4% acknowledged sharing nail tools. Notably, 75.7% preferred professional assistance for symptoms, with 24.3% opting for home remedies. Gender disparities were evident, with women showing significantly better hygiene practices and pool usage than men (<i>p</i> < 0.001). Women also exhibited a stronger tendency to disinfect grooming tools and prioritise sterility during beautician services (<i>p</i> < 0.001). These findings emphasise the importance of gender-specific health behaviour analysis in promoting preventive measures.</p><p><strong>Conclusions: </strong>The study highlights onychomycosis as a significant societal concern. Pre-COVID-19, awareness among municipal swimming pool users regarding prevention, symptoms, and treatment of athlete's foot and onychomycosis was insufficient.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 2","pages":"226-231"},"PeriodicalIF":1.4,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110223/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141088990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rui Huang, Yi Zhuang, Yuan Chang, Lin-Feng Li, Hong-Jun Xu
{"title":"A retrospective analysis of comorbidities in patients with psoriasis at a single centre.","authors":"Rui Huang, Yi Zhuang, Yuan Chang, Lin-Feng Li, Hong-Jun Xu","doi":"10.5114/ada.2024.139123","DOIUrl":"10.5114/ada.2024.139123","url":null,"abstract":"<p><strong>Introduction: </strong>Psoriasis is a chronic inflammatory disease occurring worldwide. It is currently considered a multi-system disease, which is associated with several comorbidities.</p><p><strong>Aim: </strong>To deeply understand the clinical characteristics of psoriasis comorbidities and explore the relationship between psoriasis comorbidities, different subtypes and related influencing factors.</p><p><strong>Material and methods: </strong>This retrospective study analysed data from the electronic inpatient medical record system of dermatology and non-dermatology departments at a tertiary hospital in China. We collected relevant demographic data and clinical features of all patients diagnosed with psoriasis from January 2013 to September 2023.</p><p><strong>Results: </strong>This study ultimately included a total of 1097 patients with psoriasis. Psoriasis vulgaris was the most common among the subtypes of psoriasis, with 957 (87.2%) cases. The sample consisted of 65.6% of males and 34.4% of females, with an average age of 53.5 ±15.2 years. Common comorbidities of psoriasis included hypertension (38.2%), hyperlipidaemia (29.4%), type 2 diabetes mellitus (24.6%), fatty liver disease (21.4%), coronary heart disease (21.0%), tumours (15.5%), gastroduodenal disease (14.4%), osteoarthropathy (11.8%), and cerebrovascular disease (10.8%). The incidence of hypertension (<i>p</i> = 0.015), hyperuricemia (<i>p</i> < 0.001), osteoarthropathy (<i>p</i> < 0.001), and autoimmune disease (<i>p</i> = 0.003) among different subtypes of psoriasis showed statistically significant differences. In addition, gender, smoking and alcohol consumption all have significant impacts on the distribution of comorbidities.</p><p><strong>Conclusions: </strong>The distribution of psoriasis comorbidities and complications varies among different subtypes of psoriasis. Lifestyles such as smoking and alcohol abuse, as well as gender, are also associated with the occurrence of psoriasis comorbidities.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 2","pages":"164-172"},"PeriodicalIF":1.4,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141088787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shahad Fahmi Dhaiban, Salaa Zaki Abduljabbar Alfadagh, Zahraa Mahmood Jasim
{"title":"Post-COVID pigment loss: the connection between vitiligo and the pandemic.","authors":"Shahad Fahmi Dhaiban, Salaa Zaki Abduljabbar Alfadagh, Zahraa Mahmood Jasim","doi":"10.5114/ada.2024.138670","DOIUrl":"10.5114/ada.2024.138670","url":null,"abstract":"<p><strong>Introduction: </strong>Vitiligo is an acquired disorder characterized by the progressive loss of functional melanocytes, resulting in depigmented macules and patches on the skin. It affects a significant portion of the world's population, with no specific gender or geographic predilection.</p><p><strong>Aim: </strong>To explore the current understanding of the association between vitiligo and COVID-19.</p><p><strong>Material and methods: </strong>This is a cross-sectional comparative research of 90 vitiligo patients, separated into two groups: those with COVID-19 confirmed by PCR and those without, gathered in 2018 before the pandemic. Al-Sadar teaching hospital in Al Basra gathered data from March 2021 to May 2022. Vitiligo patients with other infections were excluded. Wood's test was used to confirm vitiligo (VASI score). Age, gender, site of vitiligo, number of lesions, and family history were gathered for all patients in both groups.</p><p><strong>Results: </strong>Patients with vitiligo and COVID-19 had mild (70.27%), moderate (18.92%), and severe (10.81%) infections. Significant differences were found in age, duration, and VASI score, with younger patients and lower VASI scores in the Vitiligo + COVID-19 group. Females (60.6%) were more affected, and lower limbs (66.7%) were the most common site of vitiligo lesions in COVID-19 patients.</p><p><strong>Conclusions: </strong>70.27% of vitiligo and COVID-19 patients had mild infections, 18.92% had moderate infections, and 10.81% had severe infections. Patients with both disorders were younger, had shorter vitiligo durations, and lower VASI scores than those with just one. Females were more likely to have both disorders, and lower limb vitiligo was more prevalent. Family history did not affect either group.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 2","pages":"197-202"},"PeriodicalIF":1.4,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141089051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Adriana Polańska, Joanna Wegner, Paula Nutbohm, Petra Staubach, Ryszard Żaba, Aleksandra Dańczak-Pazdrowska, Dorota Jenerowicz
{"title":"Afamelanotide in protoporphyria and other skin diseases: a review.","authors":"Adriana Polańska, Joanna Wegner, Paula Nutbohm, Petra Staubach, Ryszard Żaba, Aleksandra Dańczak-Pazdrowska, Dorota Jenerowicz","doi":"10.5114/ada.2024.138818","DOIUrl":"10.5114/ada.2024.138818","url":null,"abstract":"<p><p>Afamelanotide is a synthetic alpha melanocyte stimulating hormone presenting a higher activity than natural hormones. Its main properties are related to the enhanced production of eumelanin by agonistically binding to the melanocortin-1 receptor. Since 2016 afamelanotide has been especially applied to treat cases of erythropoietic porphyria (EPP), where painful photosensitivity has been observed since early childhood. The positive effect of afamelanotide in EPP administered subcutaneously improved tolerance to artificial white light and increased pain-free time spent in direct sunlight. In this review we summarize the possible use of afamelanotide in dermatology, with special emphasis on EPP and encourage including afamelanotide as a treatment option in patient care.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 2","pages":"149-154"},"PeriodicalIF":1.4,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110213/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141088811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mikołaj Łanocha, Aleksandra Frątczak, Anna Tekielak, Bartosz Miziołek, Beata Bergler-Czop
{"title":"Misfortunes never come singly but in fours - follicular occlusion tetrad.","authors":"Mikołaj Łanocha, Aleksandra Frątczak, Anna Tekielak, Bartosz Miziołek, Beata Bergler-Czop","doi":"10.5114/ada.2024.138652","DOIUrl":"10.5114/ada.2024.138652","url":null,"abstract":"","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 2","pages":"245-249"},"PeriodicalIF":1.4,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110217/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141089046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hubert Arasiewicz, Joanna Czuwara, Michał Dec, Lilianna Leśniak-Jakubiec
{"title":"Senear-Usher syndrome in a 5-year-old girl.","authors":"Hubert Arasiewicz, Joanna Czuwara, Michał Dec, Lilianna Leśniak-Jakubiec","doi":"10.5114/ada.2024.139233","DOIUrl":"10.5114/ada.2024.139233","url":null,"abstract":"","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 2","pages":"242-244"},"PeriodicalIF":1.4,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110225/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141089015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Wojciech Żurek, Magdalena Baron, Łukasz Moos, Katarzyna Kapeluszna, Liwia Starczewska-Dymek, Zenon Brzoza
{"title":"Vaccination against the SARS-CoV-2 virus in patients undergoing Hymenoptera venom immunotherapy.","authors":"Wojciech Żurek, Magdalena Baron, Łukasz Moos, Katarzyna Kapeluszna, Liwia Starczewska-Dymek, Zenon Brzoza","doi":"10.5114/ada.2024.139136","DOIUrl":"10.5114/ada.2024.139136","url":null,"abstract":"<p><strong>Introduction: </strong>The SARS-CoV-2 epidemic has unquestionably left a significant mark on the global healthcare system. Implementation of the commonly available vaccinations against COVID-19 is intended to reduce the risk of a severe course of the disease. Due to a very brief development period of the new vaccines, concerns have appeared among the public with regard to the possible adverse effects of the newly-developed preparations, as well as to the risks of causing allergic reactions. Regular medical observation during the Hymenoptera venom immunotherapy provides significant possibilities to note any potential adverse effects of vaccines against COVID-19, as well as of complications of an experienced SARS CoV-2 infection.</p><p><strong>Aim: </strong>To assess the issues connected with vaccination against COVID-19, complications following vaccination, as well as incidence and course of the disease among patients undergoing venom immunotherapy (VIT) due to an allergy to Hymenoptera venom.</p><p><strong>Material and methods: </strong>We investigated 37 persons aged 19 to 70 (20 women; 17 men) undergoing Hymenoptera venom immunotherapy in our department.</p><p><strong>Results: </strong>21.6% have experienced an infection with the SARS-CoV-2 virus, confirmed by a diagnostic test. No person participating in the study had experienced a severe infection which would require hospitalization. Elderly people have been vaccinated statistically significantly more often than young people.</p><p><strong>Conclusions: </strong>The risk related to vaccination in this group of patients does not seem to be higher than in the general population.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 2","pages":"215-219"},"PeriodicalIF":1.4,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110222/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141089067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical evaluation of continuous irrigation with Bikerui combined with negative pressure closed drainage and platelet-rich plasma technique for treatment of stage III-IV pressure ulcer.","authors":"Yuxin Liu, Na Chen","doi":"10.5114/ada.2024.138675","DOIUrl":"10.5114/ada.2024.138675","url":null,"abstract":"<p><strong>Introduction: </strong>As a catastrophic complication of bedridden and elderly patients, pressure ulcer usually continuously affects patients' health and quality of life, so the daily care of wounds is attached great importance in clinic.</p><p><strong>Aim: </strong>This work investigated the effect of Bikerui disinfectant + vacuum sealing drainage (VSD) + platelet-rich plasma (PRP) therapy on patients with stage III ~ IV pressure sore.</p><p><strong>Material and methods: </strong>In this work, 110 patients with pressure ulcer (PU) treated in our hospital were enrolled and were randomly divided into an experimental group (Exp group) and a control group (Ctrl group) by a blind selection method, with 55 cases in each group. Patients in the Ctrl group received surgical debridement + VSD for treatment, while those in the Exp group were treated with Bikerui disinfectant + VSD + PRP. Inflammatory response (IR) score, PU healing (PUH) score, healing time, dressing change frequency (DCF), dressing interval time (DIT), and scar recovery (SR) score of patients in different groups were compared.</p><p><strong>Results: </strong>The results revealed that the positive rate of bacterial culture in wound secretions in the Exp group was greatly lower than that in the Ctrl group 1 or 2 weeks after treatment (<i>p</i> < 0.05). The IR score in the Exp group was much lower at week 1 and 2 after treatment (<i>p</i> < 0.05). The total effective rate (TER) in the Exp group was obviously higher than that in the Ctrl group (94.55% vs. 76.36%).</p><p><strong>Conclusions: </strong>The results suggested that Bikerui disinfectant + VSD + PRP therapy could effectively improve the inflammatory degree of PU patients, promote the wound repair and scar recovery of patients, and greatly improve the clinical efficacy of PU patients.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 2","pages":"181-188"},"PeriodicalIF":1.4,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110210/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141089027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mechanism of pruritus ani lotion combined with Huajiao-Gancao-Bingpian oil for pruritus ani treatment based on network pharmacology and molecular dynamics.","authors":"Wenkuo Deng, Minghong Fu, Jintao Huang","doi":"10.5114/ada.2023.135761","DOIUrl":"10.5114/ada.2023.135761","url":null,"abstract":"<p><strong>Introduction: </strong>Pruritus ani lotion combined with a Chinese medicine formula named Huajiao (Pericarpium Zanthoxyli Bungeani)-Gancao (Radix Glycyrrhizae)-Bingpian (Borneol) is effective in treating pruritus ani.</p><p><strong>Aim: </strong>To investigate the mechanism of traditional Chinese medicine (TCM) in pruritus ani via network pharmacology and molecular dynamics (MD).</p><p><strong>Material and methods: </strong>The Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) was utilised to screen active ingredients and their corresponding targets. Genes associated with pruritus ani were collected through GeneCards. Protein-protein interaction (PPI) network between target genes of the active ingredients of this formula and genes associated with pruritus ani was established through the STRING database. A drug-active ingredient-gene interaction network was constructed using Cytoscape with the top 50 genes in affinity coefficients. Molecular docking and MD simulation analysis were performed.</p><p><strong>Results: </strong>Epidermal growth factor receptor (EGFR) and Signal Transducer and Activator of Transcription 3 (STAT3) were core genes. Direct targeting of EGFR by the active ingredients (quercetin and luteolin) and direct targeting of STAT3 by the active ingredient (licochalcone A) may be key molecular mechanisms for the treatment of pruritus ani. Simulated trajectories of structural nuclear motion by MD also revealed that the binding of two pairs of molecules was relatively stable.</p><p><strong>Conclusions: </strong>This study unravels potential targets, active ingredients, and mechanisms of pruritus ani lotion combined with Huajiao-Gancao-Bingpian oil in the treatment of pruritus ani, providing a reference for future treatment.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"41 2","pages":"203-214"},"PeriodicalIF":1.4,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110214/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141089038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}